De-risking PML: A conversation with Prof. Walter Atwood

ECTRIMS 2018

De-risking PML: A conversation with Prof. Walter Atwood

2872 2598 Prof. Dr. Krassen Nedeltchev

We interviewed Professor Walter Atwood last week at the 2018 ECTRIMS congress in Berlin, Germany, to learn about advances in treating progressive multifocal leukoencephalopathy (PML) – an important treatment-associated infection in patients with multiple sclerosis (MS). Watch the interview to listen to Professor Atwood’s insights into new ways to tackle the risks of PML, including anti-viral treatments.

Want to learn more about PML and other treatment-associated side-effects in MS? Read our previous articles here and here, and have a look at Professor Atwood’s recent research on the causative virus in PML.

Walter Atwood is a Professor of Medical Science, Director of Cancer Signaling, and Vice Chair of Molecular Biology, Cell Biology and Biochemistry at Brown University (Providence, Rhode Island, USA).

Prof. Dr. Krassen Nedeltchev

All stories by:Prof. Dr. Krassen Nedeltchev
Brainwork is supported by unrestricted grants from: